Similarly, inhibiting MCT1 in glycolytic cells could kill malignant and nonmalignant cells that use MCT1 to export lactate, unless they would compensate by increasing MCT4 expression or by switching to a more oxidative metabolism, as previously reported in cancer cells [22,23]. The gene discussed is SLC16A1; the disease is cancer.